
Profound Medical Corp. PROF
$ 6.27
5.38%
Annual report 2023
added 12-27-2025
Profound Medical Corp. Interest Expense 2011-2026 | PROF
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Profound Medical Corp.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 146 K | 290 K | 448 K | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 448 K | 146 K | 295 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alphatec Holdings
ATEC
|
45.9 M | $ 11.25 | 3.21 % | $ 1.69 B | ||
|
AxoGen
AXGN
|
167 K | $ 33.47 | 4.72 % | $ 1.54 B | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 180.67 | 4.35 % | $ 13.5 B | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 12.32 | 1.23 % | $ 1.66 B | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.33 | 0.76 % | $ 125 M | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 288.17 | 3.19 % | $ 8.13 B | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 39.05 | 3.88 % | $ 5.82 K | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 63.18 | 2.3 % | $ 93.5 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.03 | 7.41 % | $ 1.23 M | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 10.01 | 15.32 % | $ 283 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Electromed
ELMD
|
78 K | $ 24.95 | 3.44 % | $ 211 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Inogen
INGN
|
2.44 M | $ 6.45 | 1.9 % | $ 172 M | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
LivaNova PLC
LIVN
|
664 K | $ 64.58 | 2.87 % | $ 3.52 B | ||
|
LENSAR
LNSR
|
636 K | $ 5.92 | 3.86 % | $ 70.8 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 16.95 | 6.14 % | $ 398 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 92.98 | 2.83 % | $ 12.6 B | ||
|
Butterfly Network
BFLY
|
-13 K | $ 4.28 | 4.39 % | $ 906 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
-70 K | $ 10.45 | 4.08 % | $ 374 M | ||
|
Myomo
MYO
|
-668 K | $ 0.73 | 6.34 % | $ 30.6 M | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 54.92 | 1.67 % | $ 1.61 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 38.46 | 4.68 % | $ 1.19 B | ||
|
NanoVibronix
NAOV
|
135 K | - | - | $ 1.08 M | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 87.73 | 3.08 % | $ 3.05 B | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.71 | 0.16 % | $ 123 M |